Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study.

Negrato CA, Rafacho A, Negrato G, Teixeira MF, Araújo CA, Vieira L, Silva CA, Date SK, Demarchi AC, Gomes MB.

Diabetes Res Clin Pract. 2010 Jul;89(1):46-51. doi: 10.1016/j.diabres.2010.03.015. Epub 2010 Apr 7.

PMID:
20378197
2.

Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.

Fang YM, MacKeen D, Egan JF, Zelop CM.

J Matern Fetal Neonatal Med. 2009 Mar;22(3):249-53. doi: 10.1080/14767050802638170.

PMID:
19330710
3.

Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis.

Pollex E, Moretti ME, Koren G, Feig DS.

Ann Pharmacother. 2011 Jan;45(1):9-16. doi: 10.1345/aph.1P327. Epub 2011 Jan 4. Review.

PMID:
21205954
4.

Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy.

Smith JG, Manuck TA, White J, Merrill DC.

Am J Perinatol. 2009 Jan;26(1):57-62. doi: 10.1055/s-0028-1095181. Epub 2008 Oct 31.

PMID:
18979406
5.

Perinatal outcomes in pregnancies managed with antenatal insulin glargine.

Egerman RS, Ramsey RD, Kao LW, Bringman JJ, Haerian H, Kao JL, Bush AJ.

Am J Perinatol. 2009 Sep;26(8):591-5. doi: 10.1055/s-0029-1220782. Epub 2009 Apr 15.

PMID:
19370512
6.

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

Clin Ther. 2008 Aug;30(8):1476-84. doi: 10.1016/j.clinthera.2008.08.013.

PMID:
18803989
7.

Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study--comment on Negrato et al.

Pantalone KM, Agarwal S, Faiman C.

Diabetes Res Clin Pract. 2011 Jul;93(1):e9-10; author reply e11. doi: 10.1016/j.diabres.2011.03.027. Epub 2011 Apr 19. No abstract available.

PMID:
21507497
9.

The potential for the use of insulin lispro in pregnancy complicated by diabetes.

Carr KJ, Lindow SW, Masson EA.

J Matern Fetal Neonatal Med. 2006 Jun;19(6):323-9. Review.

PMID:
16801307
10.

Insulin glargine use during pregnancy.

Pantalone KM, Faiman C, Olansky L.

Endocr Pract. 2011 May-Jun;17(3):448-55. doi: 10.4158/EP11083.RA. Review.

PMID:
21613047
11.

Use of insulin glargine during pregnancy: a case-control pilot study.

Price N, Bartlett C, Gillmer M.

BJOG. 2007 Apr;114(4):453-7. Epub 2007 Jan 25.

12.

A retrospective review of glargine use in pregnancy.

Henderson CE, Machupalli S, Marcano-Vasquez H, Kerr P, Reilly KD.

J Reprod Med. 2009 Apr;54(4):208-10.

PMID:
19438161
13.

Management of diabetes in pregnancy.

Balaji V, Seshiah V.

J Assoc Physicians India. 2011 Apr;59 Suppl:33-6.

PMID:
21823253
14.

Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine.

Rhoads GG, Kosiborod M, Nesto RW, Fonseca VA, Lu SE, Zhang Q, Foody JM.

Am J Cardiol. 2009 Oct 1;104(7):910-6. doi: 10.1016/j.amjcard.2009.05.030. Erratum in: Am J Cardiol. 2010 Aug 15;106(4):603.

PMID:
19766755
15.

Oral hypoglycaemic agents in 118 diabetic pregnancies.

Hellmuth E, Damm P, Mølsted-Pedersen L.

Diabet Med. 2000 Jul;17(7):507-11.

PMID:
10972579
16.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
17.

Safety of insulin analogs during pregnancy: a meta-analysis.

Lv S, Wang J, Xu Y.

Arch Gynecol Obstet. 2015 Oct;292(4):749-56. doi: 10.1007/s00404-015-3692-3. Epub 2015 Apr 9. Review.

PMID:
25855052
18.

A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.

Durnwald CP, Landon MB.

J Matern Fetal Neonatal Med. 2008 May;21(5):309-13. doi: 10.1080/14767050802022797.

PMID:
18446657
19.

[Switching of NPH insulin to glargine therapy in a cohort of diabetic patients: observational study].

Maia FF, Melo FJ, Araújo IM, Araújo LR.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):426-30. Portuguese.

20.

[Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].

Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T.

Dtsch Med Wochenschr. 2009 Jun;134(23):1207-13. doi: 10.1055/s-0029-1222595. Epub 2009 May 26. German. Erratum in: Dtsch Med Wochenschr. 2009 Jun;134(24):1256.

PMID:
19472091

Supplemental Content

Support Center